author-photo

André Matta

Biogen Idec

4

Papers

22

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.

2021 Lancet Neurology
Show All
- Source
- Cite
- Save
Citations (5)
Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study.

2019
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension:

2019
Show All
- Source
- Cite
- Save
Citations (1)